Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

There is scarce information on the actual incidence of candidemia in COVID-19 patients. In
addition, comparative studies of candidemia episodes in COVID-19 and non-COVID-19 …

The incidence of COVID-19-associated candidiasis (CAC) is increasing, resulting in a grave
outcome among hospitalized patients with COVID-19. The most alarming condition is the …

Background: Antimicrobials have been widely used during the COVID-19 pandemic. This
study aimed to analyze the impact of the COVID-19 pandemic on the antimicrobial …

Severely ill COVID-19 patients are at high risk of nosocomial infections. The aim of the study
was to describe the characteristics of candidemia during the pre-pandemic period (January …

Abstract Purpose of Review Corticosteroids have a complex relationship with fungal disease—
risk for many, benefit for others. This systematic review aims to address the effect of …

Abstract Coronavirus disease 2019 (COVID-19), which is attributable to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been causing a worldwide health …

Abstract Purpose of Review Invasive fungal infections are a complication of COVID-19
disease. This article reviews literature characterizing invasive fungal infections associated …